Healthcare shares were generally mixed in pre-market trade on
In healthcare stocks news, St. Jude Medical (
), a global medical device company, reports that the first patient
implants have occurred in the Portico Re-sheathable Transcatheter
Aortic Valve System U.S. IDE Trial (PORTICO trial).
The trial is evaluating the Portico Transcatheter Aortic Valve
System, the first aortic heart valve that is repositionable until
fully deployed. Data collected from the trial will be used to
support approval of the Portico Transcatheter Aortic Valve
Replacement System by the U.S. Food and Drug Administration
Shares of STJ closed the day's regular session at $64.39 and are
And, RXi Pharmaceuticals Corporation (
), which made its market debut in February, said its Q1 net loss
narrowed though revenue fell.
The net loss attributable to common shareholders was $4 million,
or $0.32 a share from $17.9, or $2.76 a share a year earlier.
Analysts were expecting $0.31, if comparable.
Finally, Eagle Pharmaceuticals (
) reported financial results for Q2, or the quarter ended March 31,
2014, with a deeper-than-expected loss while revenue topped
The specialty pharmaceutical company reported Q2 net loss of
$3.2 million or $0.36 per share, compared with the prior-year
period's $5.6 million or $1.86 per share. Revenue was $5 million,
up 2.5% from $2.5 million in the same quarter last year.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.